Israeli trial shows a fourth vaccination raises antibody levels but provides little extra protection against SARS-CoV-2 infection.
could be beneficial for people at higher risk of severe illness. Several countries, including Israel, Chile and Sweden, are offering fourth doses to older adults and other groups.
Regardless of the vaccine brand, the fourth dose raised participants’ levels of ‘neutralizing’ antibodies, which can block viral infection of cells. But levels after the fourth dose did not surpass those observed shortly after the Those antibody data might explain why the fourth dose did not translate into substantial extra protection against infection with Omicron. A four-dose course of the Pfizer vaccine was 30% more protective against infection than a three-dose course; for Moderna, that extra efficacy was 11%.That meant that, by the end of January, 52 participants who had received a fourth dose had tested positive for SARS-CoV-2 and 73 of the matched controls who had received only three doses had done so.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
COVID Omicron News: South Korea has deadliest day of pandemic amid omicron surgeThe country reported 112 fatalities in the latest 24-hour period.
Baca lebih lajut »
Fourth dose of COVID vaccine offers only slight boost against Omicron infectionIsraeli trial shows a fourth vaccination raises antibody levels but provides little extra protection against SARS-CoV-2 infection.
Baca lebih lajut »
COVID-19 cases are declining in Texas schools after omicron surgeStudent and staff COVID-19 cases are declining after districts reported the highest levels since the pandemic began. But the data is incomplete and likely an undercount.
Baca lebih lajut »
Is omicron leading us closer to herd immunity against COVID?Is omicron leading us closer to herd immunity against COVID-19? Experts say it’s not likely that the highly transmissible variant – or any other variant – will lead to herd immunity. Here’s why.
Baca lebih lajut »
Is omicron leading us closer to herd immunity against COVID?Experts say it's not likely that the highly transmissible omicron variant — or any other variant — will lead us closer to herd immunity against COVID-19.
Baca lebih lajut »